RIQAS
The largest global EQA scheme
Therapeutic Drugs
RIQAS Therapeutic Drugs programme is a bi-weekly EQA programme suitable for monitoring the perÂformance of a wide range of therapeutic drug assays
- Target scoring available
- Sample matrix is lyophilised human serum
- Weighed-in values reported for each parameter
| Cat No: | RQ9111 |
| Kit Size: | 12 x 5ml |
| Frequency: | Bi-weekly (2 x 6 monthly cycles) |
| Cycle Start Date: | March and September |
| Parameters: | |
| Amikacin | Paracetamol |
| Caffeine | Phenobarbitone |
| Carbamazepine | Phenytoin |
| Cyclosporine | Primidone |
| Digoxin | Salicylic acid |
| Ethosuximide | Theophylline |
| Gentamicin | Tobramycin |
| Lithium | Valproic acid |
| Methotrexate | Vancomycin |